Learn more

ZENTIVA KS

Overview
  • Total Patents
    659
  • GoodIP Patent Rank
    3,873
  • Filing trend
    ⇩ 39.0%
About

ZENTIVA KS has a total of 659 patent applications. It decreased the IP activity by 39.0%. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization), Czechia and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and environmental technology are NATCO PHARMA LTD, KRKA TOVARNA ZDRAVIL D D NOVO and WUXI FORTUNE PHARMACEUTICAL CO LTD.

Patent filings per year

Chart showing ZENTIVA KSs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Dammer Ondrej 169
#2 Krejcik Lukas 90
#3 Ridvan Ludek 82
#4 Dammer Ondřej 73
#5 Radl Stanislav 66
#6 Stach Jan 62
#7 Hajicek Josef 62
#8 Krejčík Lukáš 58
#9 Richter Jindrich 48
#10 Jirman Josef 41

Latest patents

Publication Filing date Title
GB202020113D0 Pharmaceutical compositions comprising Nilotinib, a method of preparation and uses thereof
GB202016450D0 Pharmaceutical compositions with low amounts of nitrosamine impurities and methods for producing the same
GB202003316D0 Pharmaceutical compositions comprising dasatinib anhydrous and uses thereof
EP3811932A1 Dosage form of apalutamide
EP3766484A1 Solid pharmaceutical dosage form comprising valsartan and sacubitril
CZ2019458A3 Method of preparing bictegravir and a solid form of bictegravir
CZ2019443A3 Crystalline forms of siponimod
CZ2019396A3 Process for preparing androgen receptor signalling inhibitors
CZ2019377A3 Photostable solid pharmaceutical composition with roxadustat and process for its preparation
CZ2019358A3 Solid forms of bictegravirus with inorganic bases
CZ2019357A3 Solid forms of bictegravirus
CZ2019332A3 Pharmaceutical formulation containing dimethyl fumarate and preparing it
CZ2019320A3 Solid forms of elafibranor
EP3572069A1 Increasing solubility and bioavailability of enzalutamide
EP3725305A1 Pharmaceutical composition containing baricitinib hydrobromide
CZ2019168A3 A pharmaceutical composition comprising abiraterone acetate
CZ2019134A3 Solid forms of apalutamide and a method for their preparation
CZ289293B6 Pharmaceutical composition of crystalline enzalutamide and preparing it
CZ2018700A3 Pharmaceutical composition for solid dosage forms
CZ2018680A3 (S) -2- (4- (1- (tert-butoxycarbonyl) piperidin-3-yl) phenyl) -2H-indazole-7-carboxylic acid salts, purification process and process for preparing niraparib